Renjie Gao
Overview
Explore the profile of Renjie Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Xie J, Hao X, Pu Q, Gao R, Li X
ACS Omega
. 2025 Feb;
10(4):3754-3770.
PMID: 39926550
In this paper, we examine the Hala'alat Mountain present at the northwestern margin of the Junggar Basin through core observation, field sample collection, microscopic identification, and provenance analysis. We also...
2.
Wang C, Cao H, Sun P, Chen L, Feng Y, Gao R
Am J Cancer Res
. 2024 Nov;
14(10):4830-4840.
PMID: 39553203
While androgen deprivation therapy (ADT) continues to be a fundamental aspect of prostate cancer treatment, the development of castration-resistant prostate cancer (CRPC) emphasizes the necessity for a more profound understanding...
3.
Zhang S, Gao R, Ding B, Li J, Wang T, Chen J, et al.
Int J Biol Macromol
. 2024 Aug;
279(Pt 1):134981.
PMID: 39182863
Combining selenium nanoparticles (SeNPs) with bioactive polysaccharides is one of the effective ways to overcome the shortcomings of SeNPs and polysaccharides and obtain novel antitumor drug candidates. In this study,...
4.
Li T, Gao R, Xu K, Pan P, Chen C, Wang D, et al.
Drug Resist Updat
. 2024 Jul;
76:101120.
PMID: 39053383
Aims: This study aimed to elucidate the biological roles and regulatory mechanisms of B-cell lymphoma 7 protein family member A (BCL7A) in acute myeloid leukemia (AML), particularly its interaction with...
5.
Gao R, Zhao P, Yan K
Clin Drug Investig
. 2024 Jul;
44(7):459-469.
PMID: 38960993
Background: Although selective serotonin reuptake inhibitors (SSRIs) are usually considered safe to use in patients with Parkinson's disease (PD), there are mixed data about their effectiveness, and only a few...
6.
Cao H, Wang D, Gao R, Chen L, Feng Y, Sun P
J Tradit Complement Med
. 2024 Jan;
14(1):19-25.
PMID: 38223804
Background And Aim: Prostate cancer is a leading malignant tumor in men, associated with a high rate of mortality. Androgen deprivation therapy is commonly used to treat prostate cancer, which...
7.
Feng Y, Cao H, Wang D, Chen L, Gao R, Sun P
Acta Biochim Pol
. 2023 Dec;
70(4):817-822.
PMID: 38099475
Background: Prostate cancer is one of the most common cancers in men worldwide. This study aims to elucidate the roles of c-Jun N-terminal kinase (JNK) in the progression of castration-resistant...
8.
Pu Q, Xie J, Li X, Zhang Y, Hu X, Hao X, et al.
ACS Omega
. 2023 Oct;
8(40):37065-37079.
PMID: 37841167
In the process of petroleum geology exploration and development, reservoir quality evaluation is an essential component. However, conventional reservoir quality evaluation methods are no longer able to provide accurate and...
9.
Cao H, Feng Y, Sun P, Chen L, Wang D, Gao R
J Cancer
. 2023 Aug;
14(12):2246-2254.
PMID: 37576403
Prostate cancer is the most common malignant tumor in men, accounting for one of the top five cancer incidences worldwide. However, there is no effective pharmacological treatment for advanced prostate...
10.
Cao H, Wu X, Gao R, Chen L, Feng Y, Wang D
J Cancer
. 2023 Aug;
14(12):2236-2245.
PMID: 37576395
QiLing Decoction (QLD) showed therapeutic effects against prostate cancer with an unclear underlying mechanism. This study explored the underlying mechanisms of QLD against castration-resistant prostate cancer (CRPC). Clinical specimens were...